Australian Researchers develop drug to halt cancer in mice
The genes involved in cancer growth are tough to tackle and making a drug against them is a big accomplishment.
A research, published in an Australian Journal named Nature, found the type of a drug helpful in halting the progression of blood and liver cancers. The experiment was done on a mice which helped in finding that cancer relapse can be checked.
The research was done by a collaboration between Walter and Eliza Institute of Medical Research, The University of Melbourne, Peter MacCallum Cancer Centre, Monash University and CSIRO.
In the conventional chemotherapy, treatments used to cause DNA damage which was irreversible and damaged the healthy cells as well.
The drugs designed now are capable of stopping the production of a specific protein essential for cancer growth.
A large number of pharmaceutical companies have tried to develop such drug but failed. The team of doctors from the Walter and Eliza Hall Institute of Medical College which co-led the research took a decade to reach this conclusion. 52 people were involved in the research.
The team will now seek partnerships with industry to take the drug in human use. The genes involved in cancer growth are tough to tackle and making a drug against them is a big accomplishment.
Along with clinical settings, the drug developed can be used for various other purposes also.